Pediatr. pro Praxi, 2006; 5: 250-256

Seborrhoeic dermatitis

MUDr. Milan Junášek
Dermatovenerologická ambulance, Nemocnice sv. Alžběty, Praha

The article depicts the causes, multiple clinical manifestations and therapy of this often-recurring dermatosis. Due to new findings involving this disease, possible and accessible forms of therapy and prevention are available.

Keywords: seborrhoeic dermatitis, ethiopathogenesis, clinical depiction and therapy

Published: December 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Junášek M. Seborrhoeic dermatitis. Pediatr. praxi. 2006;7(5):250-256.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Benáková N. Ekzémy a dermatitidy v lékařské praxi. Praha, Maxdorf s.r.o., 2006, s. 44-46, s. 71-72, s. 89-94.
    2. Braun Falco O, Plewig G, Wolff, HH. Dermatológia a venerológia. Martin, Osveta 2001, s. 393-399. Go to original source...
    3. Caputo R, Barbareschi M. Itraconazole: new horizons. Giornale Italiano di Dermatologia e Venereologia. 2002, 137-181.
    4. Caputo R, Rigoni C, Vigo GP, De Doncer P, De Michelis P, Spinelli G, Oriani A, Barbareschi M. Oral treatment with itraconazole in patients with seborrhoeic dermatitis and pityriasis capitis: clinical, mycological and laboratory evalution. Journal of the American Academy of Dermatology 2000, s. 339.
    5. Crutchfield CE. Pimecrolimus: a new treatment for seborrheic dermatitis. Cutis 2002, 70 (4), s. 207-208. Go to PubMed...
    6. Čapková Š. Dermatitis seborrhoica (seboroický ekzém) v ambulantní praxi. Forum medicinae 2000, č. 3, s. 72-75.
    7. Faergemann J. Treatment of Seborrhoeic Dermatitis with oral Terbinafine? Lancet 2001 July 21, s. 170. Go to original source... Go to PubMed...
    8. Gupta AK, Nicol KA. Ciclopirox 1 % shampoo for the treatment of seborrheic dermatitis. International Journal of Dermatology, 2006, 45 (1), s. 66-69. Go to original source... Go to PubMed...
    9. Izzo CM, Qualliariello Via G. Seborrhoeic Dermatitis in HIV Infected Patients. Journal of Clinical Investigation 2002, s. 49-50.
    10. Kojanová M, Šuková T, Štork J. Dermatitis seborrhoica. Česko-slovenská dermatologie 2005, 80 (5), s. 261-269.
    11. Meshkinpour A, Sun J, Weinstein G. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. Journal of the American Academy of Dermatology 2003 Jul, 49 (1), s. 145-7. Go to original source... Go to PubMed...
    12. Molinero LL, Gruber M, Leoni J, Woscoff A, Zwirner NW. Up-regulated Expression of MICA and Proinflammatory Cytokines in Skin Biopsies from Patient with Seborrhoeic Dermatitis. Clinical Imunology 2003, 106 (1), s. 50-54. Go to original source... Go to PubMed...
    13. Moises Alfaro CB, Caceres Rios HW, Rueda M, Velazquez Acosta A. Are Infantile Seborrheic and Atopic Dermatitis Clinical Variants of the Same Disease? International Journal of Dermatology 2002 Jun, 41 (6), s. 349-351. Go to original source... Go to PubMed...
    14. Nakabayashi A, Sei Y,Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Japanese Journal of Medical Mycology 2000, 38 (5), s. 337-341. Go to original source... Go to PubMed...
    15. Orfanos CE, Zouboulis CC. Oral Retinoids in the Treatment of Seborrhoea and Acne. Dermatology 1988, 196 (1), s. 140-147. Go to original source... Go to PubMed...
    16. Osúský P, Osúská M. Seboroická dermatitída - súčasné možnosti terapie. DERMA. 2002, 2, s. 7-15.
    17. Parry ME, Sharpe GR. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. British Journal of Dermatology 1998 Aug, 139 (2), s. 254-263. Go to original source... Go to PubMed...
    18. Rigoupoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1 % vs. betamethasone 17-valerate 0,1 % cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. British Journal of Dermatology 2004 Nov, 151 (5), s. 1071-5. Go to original source... Go to PubMed...
    19. Scaparro E, Ouadri G, Virno G, Orifici C, Milani M. Evaluation of the Efficacy and Tolerability of Oral Terbinafine in Patients with Seborrhoeic Dermatitis. British Journal of Dermatology 2001 Apr, 144 (4), s. 854-857. Go to original source... Go to PubMed...
    20. Skořepová M. Dermatitis seborrhoica. Amireport 4-5/95, s. 23-25.
    21. Sugita T, Takashima M, Shinoda T, Suto H, Unno T, Tsuboi R, Ogawa H, Nishikawa A. New Yeast Species, Malassezia dermatitis, Isolated from Patients with Atopic Dermatitis. Journal of Clinical Microbiology 2002, 40 (4), s. 1363-1367. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.